Novel PLGA-based nanoparticles for the oral delivery of insulin

References

• ChienYWHuman insulin: basic sciences to therapeutic usesDrug Dev Ind Pharm199622753789
   Web of Science ®Google Scholar
• BrangeJLangkjaerLInsulin structure and stabilityWangYJPearlmanRStability and Characterization of Protein and Peptide Drugs: Case HistoriesNew York, NYPlenum Press1993315350
   Google Scholar
• CarinoGPMathiowitzEReview on insulin delivery highlighting several enhancement strategies for oral bioavailabilityAdv Drug Deliv Rev19993524925710837700
   PubMed Web of Science ®Google Scholar
• WuZMZhouLGuoXDHP55-coated capsule containing PLGA/RS nanoparticles for oral delivery of insulinInt J Pharm20124251822248666
   PubMed Web of Science ®Google Scholar
• ZhangYWeiWLvPWangLMaGPreparation and evaluation of alginate-chitosan microspheres for oral delivery of insulinEur J Pharm Biopharm201177111920933083
   PubMed Web of Science ®Google Scholar
• MakhlofATozukaYTakeuchiHDesign and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin deliveryEur J Pharm Sci20114244545121182939
   PubMed Web of Science ®Google Scholar
• LiechtyWBCaldorera-MooreMPhillipsMASchoenerCPeppasNAAdvanced molecular design of biopolymers for transmucosal and intracellular delivery of chemotherapeutic agents and biological therapeuticsJ Control Release201115511912721699934
   PubMed Web of Science ®Google Scholar
• ZhangNLiJJiangWEffective production and controlled release of insulin by cationic β-cyclodextrin polymers from alginate/chitosan nanoparticlesInt J Pharm201039321221820394813
   PubMed Web of Science ®Google Scholar
• JainSRathiVVJainMDasCGoduguCFolate-decorated PLGA nanoparticles as a rationally designed vehicle for the oral delivery of insulinNanomedicine201271311133722583576
   PubMed Web of Science ®Google Scholar
• SugiharaHYamamotoHKawashimaYTakeuchiHEffectiveness of submicronized chitosan-coated liposomes in oral absorption of indomethacinJ Liposome Res201222727922329417
   PubMed Web of Science ®Google Scholar
• LiuJGongTFuHSolid lipid nanoparticles for pulmonary delivery of insulinInt J Pharm200835633334418281169
   PubMed Web of Science ®Google Scholar
• DamgéCMichelCAprahamianMCouvreurPNew approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrierDiabetes1988372462513292320
   PubMed Web of Science ®Google Scholar
• FlorenceATThe oral absorption of micro-and nanoparticulates: neither exceptional nor unusualPharm Res1997142592669098866
   PubMed Web of Science ®Google Scholar
• BlancoMDAlonsoMJDevelopment and characterization of protein-loaded poly(lactide-co-glycolide) nanospheresEur J Pharm Biopharm199743287294
   Web of Science ®Google Scholar
• ParajóYd’AngeloIHorváthAPLGA: poloxamer blend micro-and nanoparticles as controlled release systems for synthetic proangiogenic factorsEur J Pharm Sci20104164464920869438
   PubMed Web of Science ®Google Scholar
• KumariAYadavSKYadavSCBiodegradable polymeric nanoparticle based drug delivery systemsColloids Surf B Biointerfaces20107511819782542
   PubMed Web of Science ®Google Scholar
• MittalGCarswellHBrettRCurrieSRavi KumarMNVDevelopment and evaluation of polymer nanoparticles for oral delivery of estradiol to rat brain in a model of Alzheimer’s pathologyJ Control Release201115022022821111014
   PubMed Web of Science ®Google Scholar
• SartiFPereraGHintzenFIn vivo evidence of oral vaccination with PLGA nanoparticles containing the immunostimulant monophosphoryl lipid ABiomaterials2011324052405721377204
   PubMed Web of Science ®Google Scholar
• HosseininasabSPashaei-AslRKhandaghiAANasrabadiHTNejati-KoshkiKAkbarzadehAJooSWHanifehpourYDavaranSSynthesis, characterization, and in vitro studies of PLGA–PEG nanoparticles for oral insulin deliveryChem Biol Drug Des20148430731524684797
   PubMed Web of Science ®Google Scholar
• BazilleDPrud’hommeCBassoulletMTPEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes systemJ Pharm Sci1995844934987629743
   PubMedGoogle Scholar
• ReixNParatASeyfritzEIn vitro uptake evaluation in Caco-2 cells and in vivo results in diabetic rats of insulin-loaded PLGA nanoparticlesInt J Pharm201243721322022940208
   PubMed Web of Science ®Google Scholar
• De CamposASanchexAGrefRClavoPAlonsoMJThe effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosaEur J Pharm Sci200320738113678795
   PubMed Web of Science ®Google Scholar
• VillaASanchezATobioMCalvoPAlonsoMJDesign of biodegradable particles for protein deliveryJ Control Release200278152411772445
   PubMedGoogle Scholar
• AvgoustakisKBeletsiAPanagiZEffect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA–mPEG nanoparticlesInt J Pharm200325911512712787641
   PubMed Web of Science ®Google Scholar
• EnsignLMConeRHanesJOral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriersAdv Drug Delivery Rev201264557570
   PubMed Web of Science ®Google Scholar
• MuLFengSSA novel controlled release formulation for the anticancer drug paclitaxel (Taxol®): PLGA nanoparticles containing vitamin E TPGSJ Control Release200386334812490371
   PubMed Web of Science ®Google Scholar
• DIezFVSastreHCocaJEffect of the operating conditions on the preparations of stannous octoate from stannous oxideInd Eng Chem Res198827845
   Google Scholar
• SnedecorGWCochranWGStatistical Method9th edAmes, IAIowa State University Press1999
   Google Scholar
• Santander-OrtegaMJBastos-GonzálezDOrtega-VinuesaJLAlonsoMJInsulin-loaded PLGA nanoparticles for oral administration: an in vitro physico-chemical characterizationJ Biomed Nanotech200954553
   PubMed Web of Science ®Google Scholar
• YangJSunHSongCPreparation, characterization and in vivo evaluation of pH-sensitive oral insulin-loaded poly(lactic-co-glycolic acid) nanoparticlesDiabetes Obes Metab20121435836422151795
   PubMed Web of Science ®Google Scholar
• van de WeertMHoechstetterJHenninkWECrommelinDJThe effect of a water/organic solvent interface on the structural stability of lysozymeJ Control Release20006835135910974389
   PubMed Web of Science ®Google Scholar
• AbdelwahedWDegobertGStainmesseSFessiHFreeze-drying of nanoparticles: formulation, process and storage considerationsAdv Drug Deliv Rev2006581688171317118485
   PubMed Web of Science ®Google Scholar
• MorishitaMMorishitaITakayamaKMachidaYNagaiTNovel oral microspheres of insulin with protease inhibitor protecting from enzymatic degradationInt J Pharm19927817
   Web of Science ®Google Scholar
• TobioMSanchezAVilaAThe role of PEG on the stability in digestive fluids and in vivo fate of PEG–PLA nanoparticles following oral administrationColloid Surf B200018315323
   PubMed Web of Science ®Google Scholar
• RuanGFengSSLiQTEffects of material hydrophobicity on physical properties of polymeric microspheres formed by double emulsion processJ Control Release20028415116012468218
   PubMed Web of Science ®Google Scholar
• BendayanMZivEGingrasDBen-SassonRBar-OnHKirdonMBiochemical, and morpho-cytochemical evidence for the intestinal absorption of insulin in control and diabetic rats. Comparison between the effectiveness of duodenal and colon mucosaDiabetologia1994371191268163044
   PubMed Web of Science ®Google Scholar
• CuiF-DTaoA-JCunD-MZhangL-QShiKPreparation of insulin loaded PLGA-Hp55 nanoparticles for oral deliveryJ Pharm Sci20079642142717051590
   PubMed Web of Science ®Google Scholar
• PanYLiYJGaoPDingPTXuHZhengJMEnhancement of gastrointestinal absorption of chitosan-coated insulin-loaded poly(lactic-co-glycolic) acid nanoparticlesActa Pharm Sinica200338467470
   Google Scholar
• SunSLiangNKawashimaYXiaDCuiFHydrophobic ion pairing of an insulin–sodium deoxycholate complex for oral delivery of insulinInt J Nanomed2011630493056
   PubMed Web of Science ®Google Scholar
• KumarPSRamakrishnaSSainiTRDiwanPVInfluence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticlesPharmaize200661613617
   PubMed Web of Science ®Google Scholar
• AsadMAslamMMunirTANadeemAEffect of acacia nilotica leaves extract on hyperglycemia, lipid profile and platelet aggregation in streptozotocin induced diabetic ratsJ Ayub Med Coll20112337
   Google Scholar
• MwafySNYassinMMPhysiological changes associated with streptozotocin induced experimental diabetic ratsJ Al Azhar University–Gaza (ICBAS Special Issue)2010123135
   Google Scholar
• SajithaPCPunithaDDanyaUUdhayasankarMRBaluprakashTArumugasamyKAntidiabetic activity of anisochillusdysophylloides wall. exbenth. (lamiaceae) in streptozotocin induced Type 2 diabetes in male wistar albino ratsIJPAES201224043
   Google Scholar
• AdaramoyeOAAntidiabetic effect of kolaviron, a biflavonoid complex isolated from Garcinia kola seeds in wistar ratsAfr Health Sci20121249850623515095
   PubMed Web of Science ®Google Scholar
• TedongLTheophileDDzeufietPDDAntihyperglycemic and renal protective activities of Anacardiumoccidentale leaves in streptozotocin induced diabetic ratsAfr J Trad CAM200632335
   Google Scholar
• BolkentSBolkentSYanardagRTunaliSProtective effect of vanadyl sulfate on the pancreas of streptozotocin-induced diabetic ratsDiab Res Clin Prac200570103109
   Google Scholar
• ChenMCSonajeKChenKJSungHWA review of the prospects for polymeric nanoparticle platforms in oral insulin deliveryBiomaterials2011329826983821925726
   PubMed Web of Science ®Google Scholar